Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · HealthStream (HSTM)

HealthStream announces EVP exit and three executive promotions with performance RSU grants

Neutral Impact 3 of 5 leadership Written later

HealthStream disclosed that Executive Vice President Michael Sousa will resign effective March 31, 2025, and that three executives were promoted to EVP roles, including Michael Collier, Trisha Coady and Kevin O'Hara. Each promoted executive received performance-based RSUs with a grant date fair value of approximately $400,000, approved by the Compensation Committee on February 27, 2025. The changes were previously announced in the February 24, 2025 earnings release.

Key points

  • Michael Sousa, EVP Enterprise Applications, intends to resign effective March 31, 2025
  • Michael Collier promoted to EVP, Corporate Strategy, Development & Operations; Trisha Coady to EVP, Workforce Development Solutions; Kevin O'Hara to EVP, Enterprise Workforce Platform
  • Each promotion includes performance-based RSUs with grant date fair value of approximately $400,000, vesting in increments over 2026 to 2030, plus base salary increases

The filing

CompanyHealthStream (HSTM)
Form8-K, current report
Filed with the SECFeb 28, 2025, 4:06 PM ET
Accession number0001437749-25-005710

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:59 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 28, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.